American Cancer Society, Inc.

Campaign celebrates longest-living pancreatic cancer survivor; raises critical research funds SCOTTSDALE, Ariz., Oct. 31, 2024 /PRNewswire/ -- The Seena Magowitz Foundation (SMF) announces the launch of the "30 for 30" campaign to honor an incredible milestone—30-year pancreatic cancer survivor, Kay Kays. This campaign will celebrate the strength, courage, and resilience of survivors while raising $30,000 in two months to fund critical research, pre-clinical work, clinical trials and the expansion of the Pancreatic Cancer SOS. Diagnosed at age 44, Kay has beaten the odds in her health battle with pancreatic cancer, the third leading cause of cancer deaths. While she lost her pancreas, spleen, gallbladder and partial lung, she has kept something more valuable – hope. Today she serves as a Fierce Patient Research Advocate for The Seena Magowitz Foundation to support the over 65,000 patients annually who receive this diagnosis. The SMF is the leading non-profit organization in Pancreatic Cancer with over 20 years of funding research and clinical trials. The foundation was started by Roger Magowitz in 2006 to honor his mother. After supporting another large organization, Roger started his own 501c3 to work with medical Rockstars like Dr. Daniel Von Hoff who were doing next generation clinical trials and were at the forefront of research to eliminate pancreatic cancer. The SMF donates 100% of its fundraising towards clinical research and patient support. "Kay is a living testament to bravery and fortitude in the face of this terrible disease and she inspires every patient who is diagnosed," said Roger Magowitz. "Pancreatic cancer support starts here so we hope this campaign will open doors to significant relationships with key partners as we continue to add critical fundraising resources." While pancreatic cancer may be one of the rarest forms of cancer worldwide, it is also one of the deadliest and fastest growing. The American Cancer Society (ACS) predicts Pancreatic Cancer will claim more lives than any other form of cancer besides lung cancer. According to the National Cancer Institute and the ACS, the 5-year survival rate for all stages of pancreatic cancer combined is 13%, significantly higher than 5% where it stood in 2001 when Roger's mother lost her battle with pancreatic cancer. Kay's vision for the future is 30% survival rate by 2030. For more information, visit seenamagowitzfoundation.org or reach out to Miranda Wainberg at [email protected] SOURCE Seena Magowitz Foundation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

American Cancer Society and American Cancer Society Cancer Action Network volunteers Danyelle Musselman and Flecia R. Brown discuss how getting involved in research and advocacy can reduce cancer disparities for future generations ATLANTA, Oct. 24, 2024 /PRNewswire/ -- The American Cancer Society's recently released 2024 Breast Cancer Facts and Figures report finds breast cancer mortality rates overall have dropped by 44% since 1989, averting approximately 517,900 breast cancer deaths. However, Black women are less likely to survive their breast cancer regardless of stage at diagnosis. In addition, cancer research and other discoveries have contributed to a 33 percent age adjusted reduction in cancer mortality rates since rates peaked in 1991. But despite these significant strides, Black women continue to have the highest death rate and the shortest survival of any racial or ethnic group in the U.S. for most cancers. To address these issues, many in the Black community have partnered with organizations and healthcare systems to use their voices to educate about risk factors, support those diagnosed, advocate for public policies and engage in research to improve cancer disparities. To talk about how Black women can use their voices to address this ongoing issue, American Cancer Society and American Cancer Society Cancer Action Network volunteers Danyelle Musselman and Flecia R. Brown discuss the importance of getting involved in population research and advocating for policies that improve prevention and treatment. Danyelle Musselman is a former national sports anchor and is married to current USC Head Men's Basketball Coach Eric Musselman. They share three children: Michael, Matthew and Mariah. Musselman has worked with ACS and ACS CAN for the past 8 years through fundraising and advocacy. She got involved after her mom's breast cancer diagnosis following the loss of her grandmother to ovarian cancer and her grandfather to lung cancer. 1 – Knowing the history of mistreatment and abuse of Black communities when it comes to health and research, why do you think it's important to get involved in cancer research? Most of us in the Black community know the terrible history our ancestors were subjected to in the name of advancing medical knowledge, but we can't let that keep us from partnering with researchers who need our community to advance research the right way. For example, I got involved in the American Cancer Society's VOICES of Black Women study when I learned that the study was being led by two women of color along with an advisory board of Black women who are cross-disciplinary experts in Black women's health. That along with the American Cancer Society's 70-year history of funding and conducting some of the world's largest population cohort studies that have contributed to major discoveries like the linkage of cigarette smoke to lung cancer convinced me that I was in good hands. 2 – What is VOICES of Black Women and what is your pitch to Black women when encouraging them to enroll in the study? Just that if not us, who? If we don't actively participate in improving our own outcomes, how do we get it done? We know we're directly impacted by family history or access to screening and treatment due to insurance or income, but we have to dig deeper and really uncover the behavioral and environmental causes of the disparities we're seeing. We can't do that if we can't gather the data. This study explores topics like how racism, discrimination, social support, and generational wealth impact cancer risk and health seeking behaviors. This gives us the data to reinforce the importance of addressing these issues from a health perspective. In my view, it's about legacy, how can I play a small part in improving outcomes for generations to come. 3 – How are you helping the American Cancer Society broaden its reach and get to the study's goal of 100,000 Black women? I'm an official trained VOICES ambassador which means I've raised my hand along with over 100 other Black women nationwide to make sure other women we know are aware of the study and its importance. The research team is being very intentional about making sure this study is conducted as a partnership between the organization and Black women. Through ambassadors, we are reaching Black women wherever they are – local organizations, churches, sororities, etc. The other key point we want them to know is enrolling in the study means they are very much part of a movement to really see advancements in our own health. The American Cancer Society is committed to communicating with participants on a consistent basis regarding findings and results. 4 – Who is eligible to participate and how can a Black woman enroll? It's key that Black women between the ages of 25 and 55 who have no cancer history except basal or squamous skin cancer are part of the study so researchers can follow their journey. You also must be in one of our 20 enrollment states or DC. They can go to voices.cancer.org to learn more. I urge the women reading this to let all the women in your network know that we must participate to change outcomes. Flecia R. Brown has been a volunteer for ACS and ACS CAN for over 15 years. Flecia is an 18-year survivor of stage III triple-negative breast cancer. Cancer has touched Flecia's life in many ways. In addition to her own cancer journey, she has lost many family members, including her father, four uncles and her grandmother, to the disease. This has ignited Flecia's commitment to advocating for issues related to cancer prevention and early detection. 5 – Why is advocacy important to reducing cancer disparities in the Black community?? The doctor's office isn't the only place where decisions are being made about cancer. Lawmakers and policymakers in local, state and federal government also make many important decisions that have an impact on the fight against cancer. Advocacy can push lawmakers and policymakers to pass laws and fund programs that help reduce the unequal cancer burden in the Black community like those that improve access to cancer screening and treatment services. 6 – What do you do as an advocacy volunteer for ACS CAN? When I was diagnosed with breast cancer in 2005, I was self-employed at the time and knew I wouldn't be able to afford my care. Thanks to the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) -- which provides breast and cervical screenings and treatment referral services to those who are uninsured, underinsured or have limited-income -- I was able to complete my treatments without financial burden. I advocate for funding of the NBCCEDP and tell my story because no person should have to go through cancer with financial worries. As lead ACS CAN volunteer for Georgia's 14th Congressional District. I help mobilize ACS CAN volunteers in the district in support of grassroots campaigns on issues that impact the fight against cancer. I work with them and ACS CAN staff to build relationships with elected officials in our community and advocate for laws that help reduce the cancer burden. I am also a member of ACS CAN's Black Volunteer Caucus (BVC). The BVC works to decrease death and suffering from cancer, specifically in the Black community, and ensure no one is disadvantaged in the fight against the disease. We engage in meaningful advocacy and policy work nationally and locally such as hosting fireside chats to bring together researchers, physicians, legislators and allies to discuss the unique cancer disparities Black people face and policy solutions to address them. 7 – How can other Black women use their voice in communities to advocate for laws that help reduce the cancer burden in their communities? We can't end cancer as we know it for everyone if we don't increase access to quality, affordable health care. There are several ways Black women can help. They can become a volunteer and work with advocacy organizations like ACS CAN to advocate for policy changes at all levels of government. Because cancer is an election issue, they can also make their voices heard by making a plan to vote and taking the time to register to vote or check their voter registration. To learn more and enroll in the American Cancer Society's VOICES of Black Women study, visit voices.cancer.org. To learn more about ACS CAN's advocacy work in your community and become a volunteer, visit fightcancer.org/bvc. About The American Cancer Society The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 110 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit cancer.org or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, X, and Instagram. About ACS CAN The American Cancer Society Cancer Action Network (ACS CAN) advocates for evidence-based public policies to reduce the cancer burden for everyone. We engage our volunteers across the country to make their voices heard by policymakers at every level of government. We believe everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer. Since 2001, as the American Cancer Society's nonprofit, nonpartisan advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in cities, states and our nation's capital. Join the fight by visiting .  SOURCE American Cancer Society WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

10月23日，默沙东表示，公司已斥资高达13亿美元收购Modifi Biosciences，获得其实验性癌症疗法的使用权。 作为交易的一部分，Modifi有资格获得高达13亿美元的潜在里程碑付款，默沙东预付了3000万美元，以获得一类新的治疗方法KL-50——正在开发用于治疗难以治疗的脑肿瘤，包括恶性胶质瘤。 Modifi Biosciences 联合创始人、耶鲁大学医学院治疗放射学教授、耶鲁大学脑肿瘤中心科学主任 Harvey 和 Kate Cushing 医学博士表示，在创立 Modifi Biosciences 时，我们试图从根本上改变胶质母细胞瘤和其他肿瘤癌症患者的肿瘤治疗模式，我们很荣幸默克认识到我们科学的潜力，作为一家肿瘤学公司，他们完全有能力通过临床试验和商业化来推进我们的创新。 Modifi Biosciences 的研究已通过学术创始人于 2022 年在《科学》杂志上发表的初步工作以及随后在许多肿瘤模型中令人信服的临床前数据得到验证，包括神经胶质瘤和其他具有内在 DNA 修复缺陷的癌症的患者来源异种移植模型。 默沙东研究实验室发现肿瘤学副总裁 David Weinstock 博士表示，DNA 修复缺陷是肿瘤细胞的常见标志，也是对癌症治疗产生耐药性的主要原因，优秀的 Modifi Biosciences 团队开发了一种创新方法，我们相信这种方法有可能治疗一些最难治的癌症类型。 Modifi Biosciences 成立于 2021 年是一家临床前阶段的公司，其开发的癌症疗法旨在通过修改癌症DNA来选择性地杀死癌细胞。迄今为止，Modifi已经筹集了1070万美元的种子资金，并得到了包括美国癌症协会投资部门BrightEdge在内的投资者的支持。 End 声明：本公众号所有发文章(包括原创及转载文章)系出于传递更多信息之目的，且注明来源和作者。本公众号欢迎分享朋友圈或大群，谢绝媒体或机构未经授权以任何形式转载至其他平台。 转载/商务/投稿 | 联系微信15618157102（sum_Gmi） 商务合作 稿件征集 点击了解详情 往期回顾 1 8月 | 高达22家药企裁员 2 国产首款四价HPV疫苗拟纳入优先审评 3 3. 7亿美元!今年规模最大的生物医药融资诞生